Literature DB >> 10172471

A comparative analysis of the pharmaceutical market in four European countries.

L Garattini1, F Salvioni, D Scopelliti, S Garattini.   

Abstract

Mesh:

Substances:

Year:  1994        PMID: 10172471     DOI: 10.2165/00019053-199406050-00003

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  3 in total

1.  Health care in the EC member states.

Authors:  M Schneider; R K Dennerlein; A Köse; L Scholtes
Journal:  Health Policy       Date:  1992-02       Impact factor: 2.980

2.  Methodological aspects of international drug price comparisons.

Authors:  F Andersson
Journal:  Pharmacoeconomics       Date:  1993-10       Impact factor: 4.981

3.  Pharmaceutical prescriptions in four European countries.

Authors:  S Garattini; L Garattini
Journal:  Lancet       Date:  1993-11-13       Impact factor: 79.321

  3 in total
  4 in total

1.  Pharmaceutical Price Schemes in Europe: Time for a 'Continental' One?

Authors:  Livio Garattini; Alessandro Curto; Nick Freemantle
Journal:  Pharmacoeconomics       Date:  2016-05       Impact factor: 4.981

2.  Lessons from international experience in controlling pharmaceutical expenditure. III: Regulating industry.

Authors:  K Bloor; A Maynard; N Freemantle
Journal:  BMJ       Date:  1996-07-06

Review 3.  Customising an international disease management model to the needs of individual countries. Application to upper gastrointestinal disease.

Authors:  A Haycox; D Dubois; M Butterworth
Journal:  Pharmacoeconomics       Date:  1998       Impact factor: 4.981

4.  Pharmaceutical regulation in Europe and its impact on corporate R&D.

Authors:  Stephan Eger; Jörg C Mahlich
Journal:  Health Econ Rev       Date:  2014-10-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.